Massive study checks safety of popular eye injection
NCT ID NCT07105228
Summary
This study looked back at health insurance records for nearly 300,000 people who received aflibercept eye injections. The goal was to understand how often a serious eye inflammation called retinal vasculitis happens after these injections. Researchers analyzed data from 2017 to 2024 to estimate the risk and describe the patients who experienced this complication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETINAL VASCULITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Regeneron Research Site
Tarrytown, New York, 10591, United States
Conditions
Explore the condition pages connected to this study.